Preliminary clinical experience with androgen administration for pre- and postmenopausal women with hypoactive sexual desire

Journal of Sex and Marital Therapy

Volumn 31, Issue 3, 2005, Pages 173-185

  Van Anders, Sari M ^a,b   Chernick, Avinoam B ^c   Chernick, Beryl A ^a   Hampson, Elizabeth ^b   Fisher, William A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c RGB 5246 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DEPOTESTOSTERONE; TESTOSTERONE; TESTOSTERONE CIPIONATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; HYPOACTIVE SEXUAL DESIRE; INJECTION; POSTMENOPAUSE; PREMENOPAUSE; SALIVA LEVEL; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; ANDROGENS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIBIDO; MENOPAUSE; MIDDLE AGED; ORGASM; SALIVA; SEXUAL BEHAVIOR; TESTOSTERONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 17844401970     PISSN: 0092623X     EISSN: None     Source Type: Journal    
DOI: 10.1080/00926230590513384     Document Type: Article

References (42)

1. Bachmann, G. A. (2002). The hypoandrogenic woman: Pathophysiologic overview. Fertility and Sterility, 77 (4, Suppl. 4), S72-S76.
2. Bachmann, G., Bancroft, J., Braunstein, G., Burger, H., Davis, S., Dennerstein, L., Goldstein, I., Guay, A., Leiblum, S., Lobo, R., Botelovitz, M., Rosen, R., Sarrel, P., Sherwin, B., Simon, J., Simpson, E., Shifren, J., Spark, R., & Traish, A. (2002). Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertility and Sterility, 77, 660-665.
3. Bancroft, J. (2002). Sexual effects of androgens in women? Some theoretical considerations. Fertility and Sterlity, 77 (4, Suppl. 4), S55-S59.
4. Basson, R. (1999). Androgen replacement for women. Canadian Family Physician, 45, 2100-2107.
5. Basson, R. (2001). Using a different model for female sexual response to address women's problematic low sexual desire. Journal of Sex & Marital Therapy, 27, 395-403.
6. Basson, R. (2002). The complexities of female sexual arousal disorder: Potential role of pharmacotherapy. World Journal of Urology, 20, 119-126.
7. Burger, H. G. (2002). Androgen production in women. Fertility and Sterility, 77 (4, Suppl. 4), S3-S5.
8. Burger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000). A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. The Journal of Clinical Endocrinology and Metabolism, 85, 2832-2838.
9. Davis, A., Gilbert, K., Misiowiec, P., & Riegel, B. (2003). Perceived effects of testsoterone replacement therapy in perimenopausal and postmenopausal women: An internet pilot study. Health Care for Women International, 24, 831-848.
10. Davis, S. R. (1998). The clinical use of androgens in female sexual disorders. Journal of Sex & Marital Therapy, 24, 153-163.
11. Davis, S. R. (1999). The therapeutic use of androgens in women. Journal of Steroid Biochemistry and Molecular Biology, 69, 177-184.
12. Decker, D. A., Pettinga, J. E., VanderVelde, N., Huang, R. R., Kestin, L., & Burdakin, J. H. (2003). Estrogen replacement therapy in breast cancer survivors: A matched-controlled series. Menopause, 10, 277-285.
13. Fisher, W. A., Boroditsky, R., & Bridges, M. L. (1999). The 1998 Canadian contraceptive study. Canadian Journal of Human Sexuality, 8, 161-216.
14. Frank, E., Anderson, C., & Rubinstein, D. (1978). Frequency of sexual dysfunction in "normal" couples. New England Journal of Medicine, 299, 111-115.
15. Galyer, K. T., Conaglen, H. M., Hare, A., & Conaglen, J. V. (1999). The effects of gynecological surgery on sexual desire. Journal of Sex & Marital Therapy, 25, 81-88.
16. Goldstat, R., Briganti, E., Tran, J., Wolfe, R., & Davis, S. R. (2003). Transdermal testosterone therapy impvroves well-being, mood, and sexual function in premnopausal women. Menopause, 10, 390-398.
17. Greenblatt, R. B., Barfield, W. E., Garner, J. F., Calk, G. L., & Harrod, J. P. (1950). Evaluation of an estrogen, androgen, estrogen-androgen combination, and a placebo in the treatment of the menopause. Journal of Clinical Endocrinology and Metabolism, 10, 1547-1558.
18. Guay, A. T. (2001). Decreased testosterone in regularly menstruating women with decreased libido: A clinical observation. Journal of Sex & Marital Therapy, 27, 513-519.
19. Guay, A. T., & Jacobson, J. (2002). Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido. Journal of Sex & Marital Therapy, 28(Suppl.), 129-142.
20. Kaplan, H. S., & Owett, T. (1993). The female androgen deficiency syndrome. Journal of Sex & Marital Therapy, 19, 3-24.
21. King, B. E., & Allgeier, E. R. (2000). The Sexual Desire Inventory as a measure of sexual motivation in college students. Psychological Reports, 86, 347-350.
22. Laumann, E. O., Paik, A., & Rosen, R. C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. Journal of the American Medical Association, 281, 537-544.
23. Lobo, R. A., Rosen, R. C., Yang, H.-M., Block, B., & Van Der Hoop, R. G. (2003). Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertility and Sterility, 79, 1341-1352.
24. Luu-The, V., Dufort, I., Pelletier, G., & Labrie, F. (2001). Type 5 17-beta-hydroxysteroid dehydrogenase: Its role in the formation of androgens in women. Molecular and Cellular Endocrinology, 171, 77-82.
25. Michael, R. T., Gagnon, J. H., Laumann, E. O., & Kolata, G. (1994). Sex in America: A definitive survey. New York: Little, Brown.
26. Munarriz, R., Talakoub, L., Flaherty, E., Gioia, M., Hoag, L., Kim, N. N., Traish, A., Goldstein, I., Guay, A., & Spark, R. (2002). Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: Androgen and questionnaire results. Journal of Sex & Marital Therapy, 28(Suppl.), 165-173.
27. Navarro, M. A., Juan, L., Bonnin, M. R., & Villabona, C. (1986). Salivary testosterone: Relationship to total and free testosterone in serum. Clinical Chemistry, 32, 231-232.
28. Riley, A., & Riley, E. (2000). Controlled studies on women presenting with sexual drive disorder: I. Endocrine status. Journal of Sex & Marital Therapy, 26, 269-283.
29. Sarrel, P. M. (2000). Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. Journal of Women's Health and Gender-Based Medicine, 9 (Suppl. 1), S25-S32.
30. Sherwin, B. B. (1988). A comparative analysis of the role of androgen in human male and female behavior: Behavioral specificity, critical thresholds, and sensitivity. Psychobiology, 16, 416-425.
31. Sherwin, B. B. (2002). Randomized clinical trials of combined estrogen-androgen preparations: Effects on sexual functioning. Fertility and Sterility, 77(4, Suppl. 4), S49-S54.
32. Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., Caramelli, K. E., & Mazur, N. A. (2000). Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. New England Journal of Medicine, 343, 682-688.
33. Spector, I. P., Carey, M. P., & Steinberg, L. (1998). Sexual Desire Inventory. In C. M. Davis, W. L. Yarber, R. Bauserman, G. Schreer, & E. L. Davis (Eds.), Handbook of Sexuality-Related Measures (pp. 174-176). Thousand Oaks, CA: Sage Publishers.
34. Spector, I. P., Carey, M. P., & Steinberg, L. (1996). The sexual desire inventory: Development, factor structure, and evidence of reliability. Journal of Sex & Marital Therapy, 22, 175-190.
35. Spector, I. P., & Fremeth, S. M. (1996). Sexual behaviors and attitudes of geriatric residents in long-term care facilities. Journal of Sex & Marital Therapy, 22, 235-246.
36. Stuart, F. M., Hammond, D. C., & Pett, M. A. (1987). Inhibited sexual desire in women. Archives of Sexual Behavior, 16, 91-106.
37. Taieb, J. T., Mathian, B., Millot, F., Patricot, M. C., Mathieu, E., Queyrel, N., Lacroix, I., Somma-Delpero, C., & Boudou, P. (2003). Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry, 49, 1381-1395.
38. Talakoub, L., Munarriz, R., Hoag, L., Gioia, M., Flaherty, E., & Goldstein, I. (2002). Epidemiological characteristics of 250 women with sexual dysfunction who presented for initial evaluation. Journal of Sex & Marital Therapy, 28(Suppl.), 217-224.
39. Traish, A. M., Kim, N. N., Munarriz, R., Moreland, R., & Goldstein, I. (2002). Biochemical and physiological mechanisms of female genital sexual arousal. Archives of Sexual Behavior, 31, 393-400.
40. Tuiten, A., Van Honk, J., Koppeschaar, H., Bernaards, C., Thijssen, J., & Verbaten, R. (2000). Time course of effects of testosterone administration on sexual arousal in women. Archives of General Psychiatry, 57, 149-153.
41. Wang, C., Plymate, S., Nieschlag, E., & Paulsen, C. A. (1981). Salivary testosterone in men: Further evidence of a direct correlation with free serum testosterone. Journal of Clinical Endocrinology and Metabolism, 53, 1021-1024.
42. Waxenberg, S. E., Drellich, M. G., & Sutherland, A. M. (1959). The role of hormones in human behavior. I. Changes in female sexuality after adrenalectomy. Journal of Clinical Endocrinology and Metabolism, 19, 193-202.